0000899243-20-011019.txt : 20200420 0000899243-20-011019.hdr.sgml : 20200420 20200420181021 ACCESSION NUMBER: 0000899243-20-011019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200416 FILED AS OF DATE: 20200420 DATE AS OF CHANGE: 20200420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 20803607 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-16 0 0001552451 MyoKardia, Inc. MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 1 1 0 0 President and CEO Common Stock 2020-04-16 4 S 0 1000 55.00 D 76796 D Common Stock 2020-04-17 5 G 0 E 200865 0.00 D 122661 I By Reporting Person's Trust 3 Common Stock 2020-04-17 5 G 0 E 200865 0.00 A 277661 D Common Stock 2020-04-20 5 G 0 E 122661 0.00 D 0 I By Reporting Person's Trust 3 Common Stock 225947 I By Reporting Person's Trust 2 Common Stock 53087 I By Trust 1 Common Stock 53087 I By Trust 2 Common Stock 53087 I By Trust 3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. /s/ Cynthia J. Ladd, as Attorney-in-Fact 2020-04-20